Loading...
•
Mar 31, 2022
Myriad Genetics Q1 2022 Earnings Report
Reported first quarter revenue and reiterated guidance for 2022.
Key Takeaways
Myriad Genetics reported revenue of $164.9 million for the first quarter of 2022, representing an 11% increase year-over-year excluding revenue from divested businesses. The company's GAAP earnings per share (EPS) improved to $(0.26), and adjusted EPS improved to $(0.03).
Revenue of $164.9 million for the quarter ended March 31, 2022.
Excluding revenue from divested businesses, revenue increased 11% year-over-year.
Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively.
Ended the quarter with $339.2 million in cash, cash equivalents and investments.
Revenue by Segment
Forward Guidance
Myriad Genetics reiterated its fiscal year 2022 financial guidance.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...